Aravive

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aravive and other ETFs, options, and stocks.

About ARAV

Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies.

CEO

Gail Frances McIntyre

CEOGail Frances McIntyre

Employees

Employees23

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2008

Founded2008

Employees

Employees23

ARAV Key Statistics

Market cap

78.97M

Market cap78.97M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

140.84K

Average volume140.84K

High today

$1.36

High today$1.36

Low today

$1.28

Low today$1.28

Open price

$1.28

Open price$1.28

Volume

51.43K

Volume51.43K

52 Week high

$3.49

52 Week high$3.49

52 Week low

$0.5801

52 Week low$0.5801

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

ARAV Earnings

-$0.64

-$0.43

-$0.21

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 30, After Hours

ActualExpected Mar 30, After Hours

Aravive

Why Robinhood?

Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Show more

ARAV Key Statistics

Analyst ratings

100%

Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies.